These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation. Posner GH; Lee SH; Kim HJ; Peleg S; Dolan P; Kensler TW Bioorg Med Chem; 2005 Apr; 13(8):2959-66. PubMed ID: 15781405 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and biological evaluation of a des-C,D-analog of 2-methylene-19-nor-1alpha,25-(OH)2D3. Plonska-Ocypa K; Grzywacz P; Sicinski RR; Plum LA; DeLuca HF J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):298-304. PubMed ID: 17223343 [TBL] [Abstract][Full Text] [Related]
51. Characterization and Interconversion of Two Crystal Forms of NEt-3IB, a Retinoid X Receptor Agonist. Takamura Y; Kikuzawa S; Fujihara M; Sunatsuki Y; Higaki K; Kakuta H Chem Pharm Bull (Tokyo); 2023; 71(4):282-288. PubMed ID: 37005253 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of novel C-2 substituted vitamin D derivatives having ringed side chains and their biological evaluation on bone. Saito H; Takagi K; Horie K; Kakuda S; Takimoto-Kamimura M; Ochiai E; Chida T; Harada Y; Takenouchi K; Kittaka A J Steroid Biochem Mol Biol; 2013 Jul; 136():3-8. PubMed ID: 23416104 [TBL] [Abstract][Full Text] [Related]
53. Synthesis of 1alpha,25-dihydroxyvitamin D analogues featuring a S(2)-symmetric CD-ring core. Minne G; Verlinden L; Verstuyf A; De Clercq PJ Molecules; 2009 Feb; 14(2):894-903. PubMed ID: 19255548 [TBL] [Abstract][Full Text] [Related]
54. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly. Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157 [TBL] [Abstract][Full Text] [Related]
55. On the use of volume maps in the conformational analysis of vitamin D analogs. Van Haver D; De Clercq PJ Bioorg Med Chem Lett; 1998 May; 8(9):1029-34. PubMed ID: 9871702 [TBL] [Abstract][Full Text] [Related]
56. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway. Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554 [TBL] [Abstract][Full Text] [Related]
57. New analogs of 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D3 with conformationally restricted side chains: evaluation of biological activity and structural determination of VDR-bound conformations. Vanhooke JL; Tadi BP; Benning MM; Plum LA; DeLuca HF Arch Biochem Biophys; 2007 Apr; 460(2):161-5. PubMed ID: 17227670 [TBL] [Abstract][Full Text] [Related]
58. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor. Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332 [TBL] [Abstract][Full Text] [Related]